Procter & Gamble Hygiene and Health Care reported a surge of 36.44 per cent in its net profit at Rs 210.69 crore for the first quarter ending in September, compared to the same quarter last year.
The company, which follows the July-June financial year, had reported a profit after tax of Rs 154.41 crore in the corresponding quarter of the previous fiscal.
According to regulatory filings, the revenue from operations during July-September rose to Rs 1,138.35 crore, marking an 8.94 per cent increase from the previous year. The company attributed this growth to “superior retail execution and an integrated growth strategy,” as stated in its earnings report.
The Profit After Tax (PAT) for the quarter reached Rs 211 crore, exhibiting a 36 per cent rise compared to the previous year. This surge was attributed to increased volume growth, a favorable product price-mix, and enhanced productivity.
The company, renowned for brands like Vicks in healthcare and Whisper in feminine care, witnessed a 9.74 per cent uptick in total income to Rs 1,154.12 crore. Total expenses during the September quarter rose by 2.81 per cent to Rs 869.65 crore.
L V Vaidyanathan, the Managing Director of the company, emphasized their strong performance, stating, “We delivered a strong top and bottom line growth in the quarter by executing our integrated strategy of a focused product portfolio of daily use categories.”
Despite these positive financial outcomes, shares of Procter & Gamble Hygiene and Health Care experienced a 1.37 per cent decline, settling at Rs 16,744.25 apiece on the BSE.
